Poseida Therapeutics Stock Price, News & Analysis
Company Description
Poseida Therapeutics (NASDAQ: PSTX) is a publicly traded biological product (except diagnostic) manufacturing company in the Biological Products, (no Disgnostic Substances) sector. The company has a market capitalization of $925.9M, ranking #2,874 among all listed U.S. companies by market cap.
PSTX stock has gained 194.1% over the past year. Shares last traded at $9.50.
This page provides a comprehensive overview of PSTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Poseida Therapeutics (PSTX) stock last traded at $9.50. Over the past 12 months, the stock has gained 194.1%. At a market capitalization of $925.9M, PSTX is classified as a small-cap stock with approximately 97.5M shares outstanding.
Latest News
Poseida Therapeutics has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, acquisition, conferences, earnings. View all PSTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PSTX Company Profile & Sector Positioning
Poseida Therapeutics (PSTX) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.